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Summary
QUESTION UNDER STUDY/PRINCIPLES: This study
aimed to evaluate trends in the incidence of oesophageal
and gastric cancer by anatomical location and histology us-
ing nationally representative Swiss data.
METHODS: We included all oesophageal and gastric can-
cers recorded in 10 Swiss population-based cancer regis-
tries 1982–2011. We calculated age-standardised incidence
rates (ASIRs) per 100 000 person-years (PY) (European
standard) for both cancer sites stratified by sex, language
region (German, French-Italian), morphology and anatom-
ical location. To assess time trends, we estimated annual
percentage changes (APCs) with 95% confidence intervals
(95% CIs).
Abbreviations
95% CI 95% confidence interval
APC annual percentage change
ASIR age-standardized incidence rates
BS/BL Basel
FR Fribourg
GE Geneva
GR/GL Glarus/Graubünden
JU/NE Jura/Neuchâtel
PY person-years
SG/AR/AI Sankt Gallen/Appenzell Ausserhoden/Appenzell
Innerhoden
TI Ticino
US Unites States
VD Vaud
VS Valais
ZH Zurich
RESULTS: ASIR of oesophageal adenocarcinoma in-
creased in both sexes and language regions (p <0.001). The
steepest increase occurred in males of the German-speak-
ing region (APC 6.8%, 95% CI 5.8–7.8) with ASIRs of 0.8
per 100,000 PY in 1982–1987 and 3.9 per 100.000 PY in
2007–2011. Incidence of oesophageal squamous cell car-
cinoma decreased significantly in males of both language
regions by around –1.5% per year. In contrast, a slight but
significant increase (APC 1.4%, 95% CI 0.3–2.4]) of oeso-
phageal squamous cell carcinoma was observed in females
of the German-speaking region. We observed stable rates
for cancer of the gastric cardia. The incidence of noncar-
dia gastric cancer decreased substantially in both sexes and
language regions (p <0.001).
CONCLUSION: In Switzerland, the incidence of oesopha-
geal adenocarcinoma has risen whereas incidence of non-
cardia gastric cancer has decreased substantially as ob-
served in other developed countries.
Key words: oesophageal cancer; gastric cancer;
adenocarcinoma; squamous cell carcinoma; incidence;
Switzerland
Introduction
In Switzerland, each year approximately 500 new cases of
oesophageal carcinoma are diagnosed and over 800 cases
of gastric carcinoma. Owing to their high lethality, oeso-
phageal and gastric cancers have a substantial public health
impact in Switzerland [1, 2].
Studies in developed countries have reported substantial in-
creases in the incidence of adenocarcinoma of the oeso-
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phagus and/or gastric cardia accompanied by stabilising or
declining rates of oesophageal squamous cell carcinoma. In
the United States (US), the incidence of oesophageal ad-
enocarcinoma has risen rapidly since the mid-1970s, espe-
cially among white males, surpassing oesophageal squam-
ous cell carcinoma [3]. During the same time period, the
incidence of gastric cardia adenocarcinoma in the US also
increased [3]. Similar trends have been observed in in sev-
eral European countries (e.g. the Nordic countries [4], Ger-
many [5], Spain [6], United Kingdom [7–11]). However,
there are substantial variations in both incidence rates and
trends between countries and within regions [4, 12–15].
Data on the incidence of oesophageal adenocarcinoma in
Switzerland have been mixed, were reported for varying
timeframes and were regionally limited [4, 12, 13, 16–19].
An international study reported an increase in the incidence
of oesophageal squamous cell carcinoma in women but no
significant trends for oesophageal adenocarcinoma or can-
cer of the gastric cardia for Basel and Geneva (1973–1995)
[4]. In other studies, no increase was found for the com-
bined incidence rates of oesophageal and gastric cardia ad-
enocarcinoma in Basel (1981–1992) [12] or for oesopha-
geal adenocarcinoma in Eastern Switzerland (1989–1999)
[17]. In contrast, increasing incidence of oesophageal ad-
enocarcinoma has been reported for the canton of Vaud
(1976–1994) [18], and for central Switzerland
(1982–2007) [19].
This study aimed to evaluate trends in the incidence of oe-
sophageal cancer (by both major histological subtypes and
anatomical location) and gastric cancer (by anatomical loc-
ation) using nationally representative data over a 30-year
period.
Methods
Data sources
Data on primary oesophageal and gastric cancer diagnoses
were obtained from Swiss cantonal cancer registries that
held at least five years of consecutive data between 1982
and 2011. The study population included cases from Basel-
Stadt/Basel-Landschaft (BS/BL), Fribourg (FR), Geneva
(GE), Grison/Glarus (GR/GL), Neuchâtel/Jura (NE/JU), St.
Gallen-Appenzell (SG/AR/AI), Ticino (TI), Valais (VS),
Vaud (VD) and Zurich (ZH). The definition of primary can-
cers followed the rules defined by the International Associ-
ation of Cancer Registries (IACR) and International Asso-
ciation for Research on Cancer (IARC) [20]. With the ex-
ception of cases from TI diagnosed prior to 2003, all cancer
cases were coded according to the third edition of the In-
ternational Classification of Diseases for Oncology (ICD-
O-3). Cases from TI diagnosed prior to 2003 were coded
according to the second revision (ICD-O-2) and were auto-
matically recoded to ICD-O-3 following international
standards [21]. Proportions of death certificate only cases
decreased from 4.9% in 1982 to 0.9% in 2011 (2.0%
1982–2011). In some cancer registries, a complete and sys-
tematic matching of registered incidence cases with data
from death certificates was not carried out for all years
[22]. The proportion of death certificate only cases with
confirmed death certificate matching was 2.6% during
1982–2011. Overall, 94.3% of all cases were histologically
verified ranging from 90.4% in 1982 to 95.6% in 2011. The
Swiss Federal Statistical Office provided cantonal mid-
year population estimates for all persons with permanent
residence status within each canton.
Classification by region
Switzerland has three major language regions (German,
French, Italian) which adjoin countries sharing the same
mother tongue. There are regional cultural differences
between the language regions reflecting those of the coun-
tries bordering Switzerland. To enable a separate group in-
spection, we followed the approach of the Swiss Federal
Statistical Office (SFO) and the National Institute for Can-
cer Epidemiology and Registration (NICER) and classified
all cases into the following language regions: German-
speaking (BS/BL, GR/GL, SG/AR/AI, ZH) and French-
Italian-speaking (FR, GE, JU/NE, TI, VS, VD) [22, 23].
The language regions were formed by grouping the cantons
according to the language spoken by the majority of the
population. Overall, 85% of the permanent resident popula-
tion of the cantons grouped to the German-speaking region
indicated German as their main language. In the cantons of
the French-Italian-speaking region, 68% of the population
declared French and 17% Italian as their main language.
Because of the gradual introduction of the cantonal cancer
registries, the population covered by cancer registration in
the French-Italian-speaking region ranged from 58.3% in
1982 to 100% since 2006. Coverage in the German-speak-
ing region varied between 43.4% in 1982 and 46.9% in
2009. The coverage of the years 2010 and 2011 dropped
to 38.9% because data from the cancer registry of BS/BL
were not available at the time when the present statistical
analysis was carried out.
Classification by anatomical location and histology
Anatomical locations of oesophageal cancer were defined
as: (1) upper and middle third (ICD-O-3: C15.0, C15.1,
C15.3, C15.4), (2) lower third (ICD-O-3: C15.2, C15.5),
and (3) overlapping / not otherwise specified (NOS) (ICD-
O-3: C15.8, C15.9). Anatomical locations of gastric can-
cers were categorised into (1) cardia (ICD-O-3: C16.0),
(2) noncardia and (3) overlapping/NOS (ICD-O-3: C16.8,
C16.9). The proportion of NOS cases (ICD-O-3: Cx.9) var-
ied substantially by cancer registry from 0.9% to 39.2% for
oesophageal, and 11.2% to 26.9% for gastric cancer.
Histological categories were classified as: (1) adenocar-
cinoma (ICD-O-3: M814-M857), (2) squamous cell car-
cinoma (ICD-O-3: M8050-M8082), (3) other histology /
NOS (ICD-O-3: M800-M804, M809-M813, M858-M994).
Overall, proportions of cases with NOS histological sub-
types (ICD-O-3: M800-M804) were 7.6% in oesophageal
cancer and 6.4% in gastric cancer.
Analytical methods
To assess time trends, annual and 5-year age-standardised
incidence rates (ASIR; direct method, European standard
[24]) per 100 000 person-years (PY) were calculated using
mid-year population estimates for each canton. Estimated
annual percentage changes (APC) with 95 percent confid-
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ence intervals (95% CIs) were obtained by fitting linear re-
gression models using the natural log of annual ASIRs as
target variable and the year of incidence as predictor.
Time trends were analysed by cancer site (oesophageal
cancer, gastric cancer), histological subtype and anatomical
location. Analyses stratified by anatomical location were
restricted to cancer registries providing specified topo-
graphy information for more than 80% of their cases (ICD-
O-3: C15.0-C15.8, C16.0-C16.8), which led to exclusion
of TI and ZH. All analyses were stratified by sex and lan-
guage region.
Results
Between 1982 and 2011, 7 280 oesophageal and 15 484
gastric cancers were diagnosed in the study population. The
contributions of the regional cancer registries are shown
in table 1. APCs for oesophageal and gastric cancers by
sex, histology, anatomical location and language region are
presented in table 2.
Figure 1
Time trends in age-standardised incidence rates (ASIRs)
(European standard population) of oesophageal cancer by sex,
histological subtype and language region from 1982 to 2011.
NOS = not otherwise specified
Figure 2
Time trends in proportions of oesophageal cancer cases by sex,
histologic subtype and language region from 1982 to 2011.
ACC = adenocarcinoma; SCC = squamous cell carcinoma, Others/
NOS = other histologic subtype / not otherwise specified
Oesophageal cancer
For both sexes and all time periods under investigation, the
incidence of oesophageal cancer was higher in the French-
Italian-speaking region than the German-speaking region
owing to distinctly higher rates of oesophageal squamous
cell carcinoma (p <.001 for all time periods). For example,
the overall male ASIR in the French-Italian-speaking re-
gion ranged from 10.3–11.8 per 100 000 PY versus 5.8–8.0
per 100 000 PY in the German-speaking region. Overall,
the incidence of oesophageal cancer was stable in the
French-Italian-speaking region (male APC –0.5 [95% CI
–1.0, 0.0], female APC –0.1 [95% CI –0.7, 0.6]), but in-
creased in the German-speaking region (male APC 1.2
[95% CI 0.6, 1.8], female APC 2.5 [95% CI 1.4, 3.5]).
Oesophageal cancer was much more frequent in males than
in females (85% and 75% of oesophageal cancer occurring
in males in the German and French-Italian regions, respect-
ively). Squamous cell carcinoma represented more than
60% of all histological types of oesophageal cancer.
The incidence of oesophageal adenocarcinoma increased
significantly in both sexes and language regions during
1982–2011. The steepest increase was observed in males
of the German-speaking region (APC 6.8% [95% CI 5.8,
7.8]) with ASIRs of 0.8 per 100 000 PY in 1982–1987 and
3.9 per 100 000 PY in 2007–2011. In males of the French-
Italian-speaking region, incidence of oesophageal adeno-
carcinoma rose substantially between 1987 and 2001 (APC
6.7% [95%CI 4.3, 9.1]) followed by a plateau of approx-
imately 4.0 per 100 000 PY in subsequent years (fig. 1). In
2008–2011, both language regions showed similar ASIRs
for oesophageal adenocarcinoma in both sexes (p >0.05).
The male to female ratio for oesophageal adenocarcinoma
was 10:1 in the German-speaking region and 6.5:1 in the
French-Italian-speaking region for the latest time period.
The incidence of oesophageal squamous cell carcinoma de-
creased significantly in males of both language regions by
around –1.5% per year. In contrast, a slight but signific-
ant increase of oesophageal squamous cell carcinoma was
observed in females of the German-speaking region with
an ASIR of 0.8 per 100 000 PY in 1982–1987 and 1.4 per
100 000 PY in 2007–2011 (APC 1.4% [95% CI 0.3, 2.4)
(table 2, fig. 1). The male to female ratio of oesophageal
squamous cell carcinoma was 2.4:1 in the German-speak-
ing region and 2.9:1 in the French-Italian-speaking region.
Squamous cell carcinoma was the predominant histological
subtype of oesophageal cancer during the study period for
females of both language regions and males of the French-
Italian-speaking region. Overall, the proportion of oeso-
phageal adenocarcinoma rose substantially from
1982–2011 and became the predominant histological sub-
type (53.8%) in males of the German-speaking region, sur-
passing squamous cell carcinoma in 2007–2011 (fig. 2).
Most cancers of the upper/middle oesophagus were squam-
ous cell carcinomas (86.6%), whereas adenocarcinoma was
the more common subtype of the lower part (48.1%). In
males of both language regions, the increasing incidence
trends of oesophageal adenocarcinoma were accompanied
by an increase of cancers in the lower part of the oesophag-
us. However, in females this relationship was less clear
(table 2).
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Gastric cancer
The German-speaking region showed significantly higher
ASIRs of gastric cancer compared with the French-Italian-
speaking region in 1982–1987 (1.2-fold higher in males
and 1.4-fold higher in females, p <.001), but more similar
rates until the end of the observation period (p >0.05 in
both sexes) (fig. 3). The incidence of gastric cancer de-
creased significantly in both sexes and language regions
with APCs ranging from –1.5% (95% CI –2.0, –1.1) in fe-
males of the French-Italian-speaking region to –3.2% (95%
CI –3.7, –2.8) in females of the German-speaking region.
For cancer of the gastric cardia, no significant APCs were
observed (table 2). The male to female ratio of cancer of
the gastric cardia was 4.2:1 in the German-speaking region
and 5.5:1 in the French-Italian-speaking region. The cor-
responding ratio for noncardia gastric cancer was 1.6:1 in
both language regions. Cancer of the gastric cardia showed
stable or slightly decreasing ASIRs (p >0.05) whereas the
incidence of noncardia gastric cancer decreased signific-
antly (p <0.001) in both sexes and language regions with
APCs from –2.1% (95% CI –2.9, –1.3) in females from
the French-Italian-speaking region to –4.2% (95% CI –5.0,
–3.3) in males in German-speaking region. However, due
to high proportions of NOS gastric cancer (13–20% per
time period) these results should be interpreted with cau-
tion.
Discussion
This study reports trends on oesophageal and gastric cancer
incidence by location and histology in Switzerland from
1982 to 2011 by combining data from ten Swiss regional
cancer registries.
We observed a substantial increase of oesophageal adeno-
carcinoma in Switzerland, as in other developed countries
[3–11, 25–29]. In the German-speaking region of Switzer-
land, a continuous increase of oesophageal adenocar-
cinoma was observed throughout the study period, whereas
a plateau was reached in males of the French-Italian-speak-
ing region from 2001 onwards after a previous increase.
In males of the German-speaking region oesophageal ad-
enocarcinoma has become the predominant histology since
2007, accompanied by a corresponding decline of oesopha-
geal squamous cell carcinoma.
Tobacco smoking and alcohol consumption have re-
peatedly been shown to be the major risk factors of oe-
sophageal squamous cell carcinoma in developed coun-
tries, accounting for the large majority of all observed cases
Figure 3
Time trends in age-standardised incidence rates (ASIRs)
(European standard population) of gastric cancer by sex,
anatomical location and language region from 1982 to 2011.
NOS = not otherwise specified
Figure 4
Time trends in proportions of gastric cancer cases by sex,
anatomical location and language region from 1982 to 2011.
NOS = not otherwise specified
Table 1: Oesophageal and gastric cancer cases in Swiss cancer registries from 1982 to 2011.
Cancer registry Diagnosis period Oesophageal cancer
n (%)
Gastric cancer
n (%)
Basel Stadt / Basel Landschaft1 1982–2009 684 (9.4) 1 820 (11.8)
Fribourg2 2006–2011 117 (1.6) 140 (0.9)
Geneva2 1982–2011 866 (11.9) 1 424 (9.2)
Grison/
Glarus1
1989–2011
1992–2011
285 (3.9) 696 (4.5)
Neuchâtel/
Jura2
1982–2011
2005–2011
356
38
(4.9)
(0.5)
646
34
(4.2)
(0.2)
St. Gallen–Appenzell1 1982–2011 725 (10.0) 2 096 (13.5)
Ticino2,3 1996–2011 383 (5.3) 1 009 (6.5)
Vaud2 1982–2011 1 644 (22.6) 2 036 (13.2)
Valais2 1989–2011 456 (6.3) 939 (6.1)
Zurich1,3 1982–2011 1 726 (23.7) 4 644 (30.0)
1 German-speaking region
2 French-Italian-speaking region
3 Data from Zurich and Ticino were excluded for all analyses stratified by location (proportion of cases with unspecified location >20%).
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[30–32]. As in other European countries, smoking-related
cancers and smoking prevalence in Swiss males continues
to decrease [33]. In addition, levels of alcohol consumption
in Switzerland have been falling continuously in the last
30 years [34], especially among Swiss men [33]. However,
alcohol consumption is distinctly more frequent in the
French- and Italian-speaking region than in the German-
speaking region and smoking prevalence is slightly higher
in the French-speaking region compared with the German-
and Italian-speaking regions of Switzerland [35]. Decreas-
ing trends in male smoking prevalence and alcohol con-
sumption are likely reflected in our results showing a sub-
stantial decline in squamous cell carcinoma of the oeso-
phagus. Among Swiss women overall, increases in
smoking prevalence have preceded substantial increases
in lung cancer incidence (+16%) and mortality (+15%)
(1998–2002 to 2003–2007) [36]. However, in this study an
increasing trend of oesophageal squamous cell carcinoma
was observed only in females of the German-speaking re-
gion.
Albeit less pronounced, tobacco smoking is also associated
with an increased risk of adenocarcinoma of the oesophag-
us and gastric cardia [37, 38]. As previously mentioned,
smoking prevalence in Swiss males continues to decline,
which serves as an argument against smoking as a major
contributing factor for the increase of oesophageal adeno-
carcinoma in Switzerland [36, 39]. The major factors dis-
cussed in the context of the rising incidence of oesophageal
adenocarcinoma are increasing prevalence of gastro-oeso-
phageal reflux disease (GORD) and obesity, and decreas-
ing prevalence of Helicobacter pylori infection. Frequent
symptoms of GORD have been shown to be associated
with oesophageal adenocarcinoma. A 2010 meta-analysis
reported a 5-fold increased risk of oesophageal adenocar-
cinoma among persons reporting at least weekly GORD
symptoms and a 7-fold increase for those with daily symp-
toms, compared with individuals with less frequent or no
symptoms [40]. A recent study reported an 11% increased
risk of oesophageal adenocarcinoma for each 5 kg/m2 in-
crement of body mass index (BMI) [41]. Other studies
suggest a synergistic interaction between BMI and GORD
[42]. Based on a pooled analysis of data from the US, Aus-
tralia and European countries, Hoyo et al. estimated that
around 20% of oesophageal adenocarcinoma are attribut-
able to synergistic effects of high BMI (≥27.5 kg/m2) and
the presence of GORD [42]. Like in other developed coun-
tries, an increasing prevalence of overweight and obesity
has been observed in Switzerland. Between 1992 and 2012,
the total overweight population (BMI ≥25 kg/m2) increased
from 30.4% to 41.1% and in the obese segment (BMI ≥30
kg/m2) from 5.4% to 10.3% [33]. The prevalence of GORD
in Swiss adults was 17.6% in 2004 [43]. The disease was
Table 2: Estimated annual percentage change for oesophageal and gastric cancer by sex, histology, anatomical location and language region from 1982 to 2011.
German-speaking region French-Italian-speaking region
n APC 95% CI p-value n APC 95% CI p-value
MALES
Oesophageal cancers 2 564 1.2 0.6, 1.8 <0.001 2 854 –0.5 –1.0, 0.0 0.058
Location*
Upper/middle third 463 –1.4 –2.6, –1.7 0.027 1 216 –0.6 –1.5, 0.2 0.136
Lower third 676 2.7 1.1, 4.3 0.002 1 073 0.8 0.1, 1.6 0.024
Overlapping/NOS 190 1.8 –0.4, –4.0 0.101 269 –2.8 –4.8, –0.8 0.008
Histology
Adenocarcinoma 949 6.8 5.8, 7.8 <0.001 853 2.8 1.8, 3.8 <0.001
Squamous cell carcinoma 1 449 –1.4 –2.0, –0.7 <0.001 1 755 –1.5 –2.3, –0.8 <0.001
Others/NOS 166 –0.1 –2.2, 2.0 0.929 246 –2.4 –3.9, –0.8 0.004
Gastric cancers 5 485 –3.1 –3.6, –2.8 <0.001 3 763 –2.3 –2.9, –1.8 <0.001
Location*
Cardia 775 –0.5 –1.3, 0.4 <0.258 893 –0.7 –1.9, 0.3 0.169
Noncardia 1 295 –4.2 –5.0, –3.3 <0.001 1 507 –3.4 –4.1, –2.6 <0.001
Overlapping/NOS 623 –4.3 –5.4, –3.3 <0.001 807 –3.7 –4.7, –2.7 <0.001
FEMALES
Oesophageal cancers 856 2.5 1.4, 3.5 <0.001 1 006 –0.1 –0.7, 0.6 0.856
Location*
Upper/middle third 292 4.4 1.7, 7.1 0.002 524 0.2 –1.0, 1.4 0.719
Lower third 292 1.0 –1.0, 3.0 0.326 332 0.9 –0.4, 2.3 0.170
Overlapping/NOS 23 –0.9 –5.4, 3.4 0.647 53 –0.4 –3.4, 2.7 0.809
Histology
Adenocarcinoma 235 5.5 3.3, 7.8 <0.001 183 4.1 2.6, 5.6 <0.001
Squamous cell carcinoma 553 1.4 0.3, 2.4 0.011 704 –0.5 –1.4, 0.3 0.219
Others/NOS 68 –1.6 –4.9, 1.7 0.315 119 –1.3 –3.7, 1.1 0.286
Gastric cancers 3 771 –3.2 –3.7, –2.8 <0.001 2 465 –1.5 –2.0, –1.1 <0.001
Location*
Cardia 273 –1.5 –3.0, 0.1 0.065 267 0.0 –1.5, 1.4 0.962
Noncardia 1 124 –3.9 –4.8, –3.0 <0.001 1 163 –2.1 –2.9, –1.3 <0.001
Overlapping/NOS 522 –3.9 –5.5, –2.3 <0.001 582 –3.3 –4.8, –1.8 <0.001
95% CI = 95% confidence interval; APC = estimated annual percentage change; NOS = not otherwise specified
* Data from Zurich and Ticino were excluded for all analyses stratified by location (proportion of cases with unspecified location >20%)
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more frequent in the French-speaking region of Switzer-
land but equally distributed among the sexes. A meta-ana-
lysis of H. pylori infection, an important risk factor for
noncardia gastric cancer [44, 45], showed a nearly 40% re-
duced risk of oesophageal adenocarcinoma in people in-
fected with H. pylori [46]. Investigating the prevalence
of H. pylori infection in Swiss adolescents in 1999–2002,
Heuberger et al. found one of the lowest prevalence of H.
pylori infection in Europe (9.7%) [47]. However, observed
trends in known risk factors can only partly explain the
rising incidence and the striking predominance of oesopha-
geal adenocarcinoma in males [38].
For cancer of the gastric cardia, we observed stable rates
in both sexes and language regions. Similar results have
been reported from other developed countries (Australia
1982–1993 [26], Finland 1976–1995 [48], Netherlands
1973–2011 [49], Spain 1980–2004 [6]). In contrast, an in-
crease of both oesophageal adenocarcinoma and cancer
of the gastric cardia has been observed in Scotland
(1978–1997) [7], eastern-England (1995–2006) [8] and the
US (1974–1994) [3]. Since our analyses were based on data
with high proportions of cases with unspecified anatomical
location they should be interpreted with caution.
When adenocarcinomas of the (lower) oesophagus and
gastric cardia have been examined, they have often been
analysed together, on the assumption that both malignan-
cies share several common features and have similar risk
factors [50, 51]. However, substantial epidemiological dif-
ferences between oesophageal and gastric adenocarcinoma
have been described, suggesting that these two cancer sites
may be distinct cancer types with partly different risk
factors [52]. A recent review investigating risk factors for
oesophageal and gastric cardia adenocarcinoma reported an
association for GORD and oesophageal adenocarcinoma,
but not for GORD and adenocarcinoma of the gastric cardia
[53]. Furthermore, it remains unclear whether obesity is as-
sociated with an increased risk for adenocarcinoma of the
gastric cardia, an established risk factor for oesophageal
adenocarcinoma [53–55]
Similar to other developed countries, the incidence of non-
cardia gastric cancer decreased substantially in Switzerland
[56]. The observed decline is presumably due to decreases
in the prevalence of H. pylori infection, the main identified
risk factor of noncardia gastric cancer [44, 45, 57]. In ad-
dition, reduction in the prevalence of tobacco smoking in
males along with improvements in food preservation and
nutrition may have also contributed to the decrease of non-
cardia gastric cancer incidence [57].
Strengths and weaknesses
This is the first Swiss population-based investigation on
oesophageal and gastric cancer trends providing the most
nationwide representative findings to date. Although the
cantonal cancer registries included do not cover the entire
Swiss population, the large study sample representing the
major language regions allows generalisability of these
findings to the national level. Overall, the study population
had less than 5% of death certificate only cases for each
year under investigation indicating a high completeness of
case ascertainment. Furthermore, the collection of cancer
cases showed a high proportion of histologically verified
cases (>90% for each time period).
Population coverage of the German-speaking region was
below 50% for all time periods under investigation. There-
fore, incidence figures for the German-speaking region
might be less precise than for the French-Italian speaking
region. Another weakness of this study is the relatively
large proportion of cancer cases with unspecified anatom-
ical location. This was particularly true for gastric cancer,
with approximately 16% of all analysed cases in this group.
Because of high proportions of cases with unspecified loc-
ation (>20%), cases from ZH and TI had been excluded for
all analyses stratified by anatomical location. Population
coverage for these analyses dropped by around 25% and
14% for the German-speaking region and French-Italian-
speaking regions, respectively. Therefore these results
should be interpreted with caution. Further, the formation
of the language regions based on cantonal borders is just an
approximation of the natural language regions of Switzer-
land. Some cantons are part of more than one language
region. However, as cantonal information was the most
detailed geographical information available, no more ac-
curate allocation was possible within this work.
In Switzerland, healthcare and cancer registration is organ-
ised at the cantonal level (detailed descriptions of the Swiss
health care system and the organisation of cancer registra-
tion can be found elsewhere [58–61]). Therefore it cannot
be ruled out that regional differences in the provision of
healthcare services and/or regional differences in the com-
pleteness of cancer registration might have influenced the
results.
A major weakness of this study is the lack of information
on prevalence trends in risk and protective factors covering
the whole study period and/or periods preceding the ob-
served incidence trends. Another limitation is the difficulty
of distinguishing the organ of origin in cancers arising at
the gastro-oesophageal junction [55, 62]. To circumvent
this problem, several other studies have combined adeno-
carcinoma of the oesophagus and gastric cardia for their
analyses. However, due to the high proportion of cases with
unspecified anatomical location, this solution was not feas-
ible for our study. Moreover, there is evidence that adeno-
carcinomas of the oesophagus and gastric cardia may be
distinct cancer types, although they share some common
risk factors [52, 53]. Last but not least, the rising incidence
of oesophageal adenocarcinoma may be at least in part af-
fected by an increase in the standard use of endoscopic pro-
cedures and advances in endoscopic technology, leading to
more sensitive detection [63].
Conclusions
In Switzerland the incidence of oesophageal adenocar-
cinoma has risen, whereas incidence of noncardia gastric
cancer has substantially decreased during the study period
1982–2011. Reasons for the rising incidence in oesopha-
geal adenocarcinoma may include increases in the preval-
ence of GORD and obesity. For oesophageal squamous cell
carcinoma, mixed trends were observed, possibly related
to sex and region-specific lifestyle changes. We observed
stable rates for cancers of the gastric cardia. However, as
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a result of high proportions of these cases with unspeci-
fied location, this finding should be interpreted with cau-
tion. Further investigations are needed to identify specific
risk factors that may be responsible for the observed trends.
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Figures (large format)
Figure 1
Time trends in age-standardised incidence rates (ASIRs) (European standard population) of oesophageal cancer by sex, histological subtype
and language region from 1982 to 2011.
NOS = not otherwise specified
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Figure 2
Time trends in proportions of oesophageal cancer cases by sex, histologic subtype and language region from 1982 to 2011.
ACC = adenocarcinoma; SCC = squamous cell carcinoma, Others/NOS = other histologic subtype / not otherwise specified
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Figure 3
Time trends in age-standardised incidence rates (ASIRs) (European standard population) of gastric cancer by sex, anatomical location and
language region from 1982 to 2011.
NOS = not otherwise specified
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Figure 4
Time trends in proportions of gastric cancer cases by sex, anatomical location and language region from 1982 to 2011.
NOS = not otherwise specified
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